Given in gram doses but probably not significantly metabolised. No data pointing to CYP affinity. Four references state non-porphyrinogenicity.

(To be edited, initial data ST OCT 04) Antimycotic pyrimidine derivative in systemic use (infusion of 1 g x 4) in sepsis, meningitis, endocarditis etc. Excreted mainly in unchanged form by the kidneys, small amounts converted to fluorouracil. No indications of CYP-interaction. Australian list: safe. EPI-list: safe. South African list: use. French list: use.